ARVN
ARVINAS, INC.
NASDAQ · Healthcare · Biotechnology · US
$7.42
+4.65%Margins
Gross margin
95.9%
EBITDA margin
-7.9%
EBIT margin
-10.7%
Net margin
-3.5%
FCF margin
-58.0%
-1.8%
Return on equity
-1.6%
Return on assets
-5.6%
Return on invested capital
0.43x
Asset turnover
-$158.3M
Cash from operations
$8.53
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026